Clinical Trial Update: A Study of RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating initial RoActemra/Actemra therapy in rheumatoid arthritis and, if inadequate response, subsequent MabThera/Rituxan treatment; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MabThera (rituximab)
• RoActemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2015-09-07